|   MAGE-3 (271-279) structure | Common Name | MAGE-3 (271-279) | ||
|---|---|---|---|---|
| CAS Number | 160295-81-8 | Molecular Weight | 1058.276 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C53H79N13O10 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of MAGE-3 (271-279)MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta[1]. | 
| Name | (2R)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol | 
|---|---|
| Synonym | More Synonyms | 
| Description | MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.4±0.1 g/cm3 | 
|---|---|
| Molecular Formula | C53H79N13O10 | 
| Molecular Weight | 1058.276 | 
| Exact Mass | 1057.607300 | 
| PSA | 365.02000 | 
| LogP | 4.48 | 
| Index of Refraction | 1.642 | 
| L-Valine, L-phenylalanyl-L-leucyl-L-tryptophylglycyl-L-prolyl-N-(diaminomethylene)-L-ornithyl-L-alanyl-L-leucyl- | 
| L-Phenylalanyl-L-leucyl-L-tryptophylglycyl-L-prolyl-N-(diaminomethylene)-L-ornithyl-L-alanyl-L-leucyl-L-valine |